ADC Therapeutics SA Adjustments For Increase Decrease In Trade And Other Payables
ADC Therapeutics SA (ADCT) reported Adjustments For Increase Decrease In Trade And Other Payables of -$3.40 million for the 9-month period ending 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables · last filed 2023-11-07
- ADC Therapeutics SA adjustments for increase decrease in trade and other payables for the quarter ending 2023-09-30 was -$836.00K.
- ADC Therapeutics SA adjustments for increase decrease in trade and other payables for the quarter ending 2023-06-30 was $1.10M.
- ADC Therapeutics SA adjustments for increase decrease in trade and other payables for the quarter ending 2023-03-31 was -$3.66M, a 183.57% decline year-over-year.
- ADC Therapeutics SA adjustments for increase decrease in trade and other payables for the quarter ending 2022-12-31 was $721.00K, a 58.63% decline year-over-year.
| Period end | Adjustments For Increase Decrease In Trade And Other Payables 3 month | Adjustments For Increase Decrease In Trade And Other Payables 6 month | Adjustments For Increase Decrease In Trade And Other Payables 9 month | Adjustments For Increase Decrease In Trade And Other Payables 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$836.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | $265.00K derived: sum of 2 quarters · filed 2023-11-07 | -$3.40M 6-K · filed 2023-11-07 | -$2.68M derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | $1.10M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-08 | -$2.56M 6-K · filed 2023-08-08 | -$1.84M derived: sum of 3 quarters · filed 2023-08-08 | -$3.22M derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-03-31 | -$3.66M 6-K · filed 2023-05-09 | -$2.94M derived: sum of 2 quarters · filed 2023-05-09 | -$4.32M derived: sum of 3 quarters · filed 2023-11-07 | -$7.74M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-12-31 | $721.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | -$660.00K derived: sum of 2 quarters · filed 2023-11-07 | -$4.07M derived: sum of 3 quarters · filed 2023-11-07 | $310.00K 20-F · filed 2023-03-15 |
| 2022-09-30 | -$1.38M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | -$4.79M derived: sum of 2 quarters · filed 2023-11-07 | -$411.00K 6-K · filed 2023-11-07 | $1.33M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$3.41M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-08 | $970.00K 6-K · filed 2023-08-08 | $2.71M derived: sum of 3 quarters · filed 2023-08-08 | -$1.21M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $4.38M 6-K · filed 2023-05-09 | $6.13M derived: sum of 2 quarters · filed 2023-05-09 | $2.20M derived: sum of 3 quarters · filed 2023-05-09 | $5.27M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.74M derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | -$2.18M derived: sum of 2 quarters · filed 2023-03-15 | $884.00K derived: sum of 3 quarters · filed 2023-03-15 | $6.80M 20-F · filed 2023-03-15 |
| 2021-09-30 | -$3.93M derived: 6-K 9 month − 6-K 6 month · filed 2022-11-08 | -$859.00K derived: sum of 2 quarters · filed 2022-11-08 | $5.05M 6-K · filed 2022-11-08 | $4.78M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-06-30 | $3.07M derived: 6-K 6 month − 6-K 3 month · filed 2022-08-09 | $8.98M 6-K · filed 2022-08-09 | $8.71M derived: sum of 3 quarters · filed 2023-03-15 | $7.43M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-03-31 | $5.91M 6-K · filed 2022-05-09 | $5.64M derived: sum of 2 quarters · filed 2023-03-15 | $4.37M derived: sum of 3 quarters · filed 2023-03-15 | $2.55M derived: sum of 4 quarters · filed 2023-03-15 |
| 2020-12-31 | -$277.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | -$1.55M derived: sum of 2 quarters · filed 2023-03-15 | -$3.36M derived: sum of 3 quarters · filed 2023-03-15 | $1.92M 20-F · filed 2023-03-15 |
| 2020-09-30 | -$1.27M derived: 6-K 9 month − 6-K 6 month · filed 2021-11-02 | -$3.08M derived: sum of 2 quarters · filed 2021-11-02 | $2.20M 6-K · filed 2021-11-02 | |
| 2020-06-30 | -$1.81M derived: 6-K 6 month − 6-K 3 month · filed 2021-08-03 | $3.47M 6-K · filed 2021-08-03 | ||
| 2020-03-31 | $5.28M 6-K · filed 2021-05-06 | |||
| 2019-12-31 | -$3.42M 20-F · filed 2022-03-17 | |||
| 2018-12-31 | -$858.00K 20-F · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |